EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preparation of sodium alginate-coated microencapsulated phage vB_SalP_SE29 and evaluation of its therapeutic effect on Salmonella enteritidis infection

Yan Cheng, Jiahao Yu, Xiaochen Ren, Ruiqi Liang, Bingmei Du, Jinhong Li, Sayed Haidar Abbas Raza, Wuwen Sun, Dongxing Zhang, Lei Zhang iD

Applied and Environmental Microbiology · 2026

DOI: 10.1128/aem.02263-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied and Environmental Microbiology, 2026. Verfasst von Yan Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, College of veterinary Medicine, Jilin Agricultural University, Changchun, China. Hauptthemen laut MEDLINE: Alginates, Salmonella Phages, Phage Therapy, Salmonella enteritidis. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Education Department of Jilin Province, Department of Science and Technology of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phages have demonstrated significant therapeutic efficacy in treating infections caused by antibiotic-resistant bacteria, yet their poor stability in the gastrointestinal tract limits oral application. This study aimed to address this barrier by preparing microencapsulated phage vB_SalP_SE29 (a lytic phage against Salmonella ) using the droplet method, with gelatin, sodium alginate, and calcium chloride as wall materials. We optimized the microencapsulation process via single-factor experiments and orthogonal design, then evaluated the microspheres’ biological properties and in vivo therapeutic efficacy in a rat model of Salmonella enteritis. The optimal formulation (2% sodium alginate, 8% gelatin, and 1.65% calcium chloride) achieved an encapsulation efficiency of 86.52% and a titer of 1 × 10 7 PFU/mL. The potency remained stable in simulated gastric fluid at pH 2, was stable in 1% and 2% bile hydrochloric acid, and displayed improved release in simulated intestinal fluid. Storage at 4°C for 6 weeks reduced microencapsulated phage titer by 0.146 lg PFU/g (vs. 0.591 lg PFU/mL for free phages). Furthermore, in vivo , microencapsulated phages increased the survival rate of infected rats to 70% (vs. 40% for free phages). Microencapsulated phage also significantly reduced inflammatory factors compared to free phage and notably improved organ lesions in infected rats. These findings demonstrated that gelatin-sodium alginate-calcium chloride microencapsulation enhanced phage stability and therapeutic efficacy, supporting the potential of microencapsulated vB_SalP_SE29 as a safe bio-antimicrobial for combating Salmonella infections. IMPORTANCE Salmonella is a common gram-negative bacterium widely distributed in nature, as well as in the intestines of humans and animals, and serves as a typical representative of foodborne pathogens. Due to the increasingly prominent issue of its multidrug resistance, phage therapy has garnered extensive attention as a potential alternative. However, when administered orally, phages are readily inactivated by gastric acid, leading to a significant reduction in phage titer. As a biopolymer with excellent biocompatibility, low cost, and low toxicity, sodium alginate can form a gel through cross-linking with Ca²⁺ ions at room temperature. The preparation of microencapsulated phages effectively protects phages from gastric acid damage, thereby enhancing their antibacterial efficacy. Evaluation of relevant biological characteristics has demonstrated that microencapsulated phages significantly improve their survival ability in the gastrointestinal environment. In vivo studies have further confirmed the good efficacy and safety of these microencapsulated phages in the treatment of rat enteritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlginatesSalmonella PhagesPhage TherapySalmonella enteritidisSalmonella InfectionsBacteriophagesAnimalsRatsHexuronic AcidsGlucuronic AcidCalcium ChlorideRats, Sprague-DawleyMaleGelatinDrug Compounding

Stichwörter der Autor:innen

Salmonellamicroencapsulationphagesodium alginatetherapeutic

Substanzen

AlginatesHexuronic AcidsGlucuronic AcidCalcium ChlorideGelatin

Autor:innen und Institutionen

  • College of Animal Science and Technology, College of veterinary Medicine, Jilin Agricultural University, Changchun, China.
  • Guangdong Provincial Key Laboratory of Food Quality and Safety, South China Agricultural University, Guangzhou, China.
  • State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Borui Technology Co., Ltd., Changchun, China.

ORCID-Profile: Lei Zhang

Förderung

  • Education Department of Jilin Province
  • Department of Science and Technology of Jilin Province

Zitieren

APA

Cheng, Y., Yu, J., Ren, X., Liang, R., Du, B., Li, J., Abbas Raza, S. H., Sun, W., Zhang, D., & Zhang, L. (2026). Preparation of sodium alginate-coated microencapsulated phage vB_SalP_SE29 and evaluation of its therapeutic effect on Salmonella enteritidis infection. Applied and Environmental Microbiology. https://doi.org/10.1128/aem.02263-25

Vancouver

Cheng Y, Yu J, Ren X, Liang R, Du B, Li J, et al. Preparation of sodium alginate-coated microencapsulated phage vB_SalP_SE29 and evaluation of its therapeutic effect on Salmonella enteritidis infection. Applied and Environmental Microbiology. 2026. doi:10.1128/aem.02263-25

BibTeX
@article{Cheng2026,
  author = {Cheng, Yan and Yu, Jiahao and Ren, Xiaochen and Liang, Ruiqi and Du, Bingmei and Li, Jinhong and Abbas Raza, Sayed Haidar and Sun, Wuwen and Zhang, Dongxing and Zhang, Lei},
  title = {Preparation of sodium alginate-coated microencapsulated phage vB_SalP_SE29 and evaluation of its therapeutic effect on Salmonella enteritidis infection},
  journal = {Applied and Environmental Microbiology},
  year = {2026},
  doi = {10.1128/aem.02263-25}
}
Kostenlos starten →